<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34220713</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>22</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">1664-2392</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>12</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in endocrinology</Title>
          <ISOAbbreviation>Front Endocrinol (Lausanne)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Letrozole for Female Infertility.</ArticleTitle>
        <Pagination>
          <StartPage>676133</StartPage>
          <MedlinePgn>676133</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">676133</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fendo.2021.676133</ELocationID>
        <Abstract>
          <AbstractText>Letrozole, an aromatase inhibitor that blocks estrogen synthesis by inhibiting the final step of the estrogen biosynthetic pathway, has been used in the applications of a wide range of infertility settings. It has been more than 20 years since the initial clinical trial of letrozole for ovulation induction. In light of the accumulating clinical and basic evidence, the efficacy and safety of letrozole have been identified. This mini review focuses on our current knowledge of the applications and mechanisms of letrozole for female infertility and various questions are put forward about how letrozole could be more effectively used.</AbstractText>
          <CopyrightInformation>Copyright © 2021 Yang, Cui, Sun and Hao.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yang</LastName>
            <ForeName>Ai-Min</ForeName>
            <Initials>AM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cui</LastName>
            <ForeName>Na</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Yi-Fei</ForeName>
            <Initials>YF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hao</LastName>
            <ForeName>Gui-Min</ForeName>
            <Initials>GM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Endocrinol (Lausanne)</MedlineTA>
        <NlmUniqueID>101555782</NlmUniqueID>
        <ISSNLinking>1664-2392</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D047072">Aromatase Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>7LKK855W8I</RegistryNumber>
          <NameOfSubstance UI="D000077289">Letrozole</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D047072" MajorTopicYN="N">Aromatase Inhibitors</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007247" MajorTopicYN="N">Infertility, Female</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077289" MajorTopicYN="N">Letrozole</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">endometrium preparation</Keyword>
        <Keyword MajorTopicYN="Y">fertility preservation</Keyword>
        <Keyword MajorTopicYN="Y">frozen-thawed embryo transfer</Keyword>
        <Keyword MajorTopicYN="Y">letrozole</Keyword>
        <Keyword MajorTopicYN="Y">ovulation induction (OI)</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>5</Day>
          <Hour>10</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34220713</ArticleId>
        <ArticleId IdType="pmc">PMC8245002</ArticleId>
        <ArticleId IdType="doi">10.3389/fendo.2021.676133</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Bhatnagar AS. The Early Days of Letrozole. Breast Cancer Res Treat (2007) 105(Suppl 1):3–5. 10.1007/s10549-007-9699-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10549-007-9699-0</ArticleId>
            <ArticleId IdType="pmc">PMC2001227</ArticleId>
            <ArticleId IdType="pubmed">17912632</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, et al. . A Randomized Trial of Letrozole in Postmenopausal Women After Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer. N Engl J Med (2003) 349:1793–802.  10.1056/NEJMoa032312
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa032312</ArticleId>
            <ArticleId IdType="pubmed">14551341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bhatnagar AS, Batzl C, Häusler A, Nogués V. The Role of Estrogen in the Feedback Regulation of Follicle-Stimulating Hormone Secretion in the Female Rat. J Steroid Biochem Mol Biol (1993) 47:161–6. 10.1016/0960-0760(93)90070-D
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0960-0760(93)90070-D</ArticleId>
            <ArticleId IdType="pubmed">8274431</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mitwally MFM, Casper RF. Aromatase Inhibition A Novel Method of Ovulation Induction in Women With Polycystic Ovary Syndrome. Reprod Technol (2000) 10:244–7.</Citation>
        </Reference>
        <Reference>
          <Citation>
Legro RS, Brzyski RG, Diamond MP, Coutifaris C, Schlaff WD, Casson P, et al. . Letrozole Versus Clomiphene for Infertility in the Polycystic Ovary Syndrome. N Engl J Med (2014) 371:119–29. 10.1056/NEJMoa1313517
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1313517</ArticleId>
            <ArticleId IdType="pmc">PMC4175743</ArticleId>
            <ArticleId IdType="pubmed">25006718</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rajan RK, Kumar M SS, Balaji B. Soy Isoflavones Exert Beneficial Effects on Letrozole-Induced Rat Polycystic Ovary Syndrome (PCOS) Model Through Anti-Androgenic Mechanism. Pharm Biol (2017) 55:242–51. 10.1080/13880209.2016.1258425
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/13880209.2016.1258425</ArticleId>
            <ArticleId IdType="pmc">PMC6130471</ArticleId>
            <ArticleId IdType="pubmed">27927075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Huang S, Wang R, Li R, Wang H, Qiao J, Mol BWJ. Ovarian Stimulation in Infertile Women Treated With the Use of Intrauterine Insemination: A Cohort Study From China. Fertil Steril (2018) 109:872–8. 10.1016/j.fertnstert.2018.01.008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2018.01.008</ArticleId>
            <ArticleId IdType="pubmed">29778386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mukherjee S, Sharma S, Chakravarty BN. Letrozole in a Low-Cost In Vitro Fertilization Protocol in Intracytoplasmic Sperm Injection Cycles for Male Factor Infertility: A Randomized Controlled Trial. J Hum Reprod Sci (2012) 5:170–4. 10.4103/0974-1208.101014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0974-1208.101014</ArticleId>
            <ArticleId IdType="pmc">PMC3493831</ArticleId>
            <ArticleId IdType="pubmed">23162355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li SJ, Zhang YJ, Chai XS, Nie MF, Zhou YY, Chen JL, et al. . Letrozole Ovulation Induction: An Effective Option in Endometrial Preparation for Frozen-Thawed Embryo Transfer. Arch Gynecol Obstetrics (2014) 289:687–93. 10.1007/s00404-013-3044-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00404-013-3044-0</ArticleId>
            <ArticleId IdType="pubmed">24121690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen D, Shen X, Fu Y, Ding C, Zhong Y, Zhou C. Pregnancy Outcomes Following Letrozole Use in Frozen-thawed Embryo Transfer Cycles: A Systematic Review and Meta-Analysis. Geburtshilfe und Frauenheilkunde (2020) 80:820–33. 10.1055/a-1202-2059
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/a-1202-2059</ArticleId>
            <ArticleId IdType="pmc">PMC7428376</ArticleId>
            <ArticleId IdType="pubmed">32817989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Dellapasqua S, Colleoni M. Letrozole. Expert Opin Drug Metab Toxicol (2010) 6:251–9. 10.1517/17425250903540246
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/17425250903540246</ArticleId>
            <ArticleId IdType="pubmed">20095792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Buzdar AU, Robertson JF, Eiermann W, Nabholtz JM. An Overview of the Pharmacology and Pharmacokinetics of the Newer Generation Aromatase Inhibitors Anastrozole, Letrozole, and Exemestane. Cancer (2002) 95:2006–16. 10.1002/cncr.10908
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cncr.10908</ArticleId>
            <ArticleId IdType="pubmed">12404296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sioufi A, Sandrenan N, Godbillon J, Trunet P, Czendlik C, Howald H, et al. . Comparative Bioavailability of Letrozole Under Fed and Fasting Conditions in 12 Healthy Subjects After a 2.5 Mg Single Oral Administration. Biopharm Drug Dispos (1997) 18:489–97. 10.1002/(SICI)1099-081X(199708)18:6&lt;489::AID-BDD36&gt;3.0.CO;2-P
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1099-081X(199708)18:6&lt;489::AID-BDD36&gt;3.0.CO;2-P</ArticleId>
            <ArticleId IdType="pubmed">9267682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mitwally MF, Casper RF. Aromatase Inhibition Improves Ovarian Response to Follicle-Stimulating Hormone in Poor Responders. Fertil Steril (2002) 77:776–80. 10.1016/S0015-0282(01)03280-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0015-0282(01)03280-0</ArticleId>
            <ArticleId IdType="pubmed">11937133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Holzer H, Casper R, Tulandi T. A New Era in Ovulation Induction. Fertil Steril (2006) 85:277–84. 10.1016/j.fertnstert.2005.05.078
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2005.05.078</ArticleId>
            <ArticleId IdType="pubmed">16595197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Weil S, Vendola K, Zhou J, Bondy CA. Androgen and Follicle-Stimulating Hormone Interactions in Primate Ovarian Follicle Development. J Clin Endocrinol Metab (1999) 84:2951–6. 10.1210/jcem.84.8.5929
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem.84.8.5929</ArticleId>
            <ArticleId IdType="pubmed">10443703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens Stimulate Early Stages of Follicular Growth in the Primate Ovary. J Clin Invest (1998) 101:2622–9. 10.1172/JCI2081
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI2081</ArticleId>
            <ArticleId IdType="pmc">PMC508852</ArticleId>
            <ArticleId IdType="pubmed">9637695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, et al. . Androgen Receptor Gene Expression in the Primate Ovary: Cellular Localization, Regulation, and Functional Correlations. J Clin Endocrinol Metab (1998) 83:2479–85. 10.1210/jcem.83.7.4917
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jcem.83.7.4917</ArticleId>
            <ArticleId IdType="pubmed">9661631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M, Bondy CA. Androgens Promote Oocyte Insulin-Like Growth Factor I Expression and Initiation of Follicle Development in the Primate Ovary. Biol Reprod (1999) 61:353–7. 10.1095/biolreprod61.2.353
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1095/biolreprod61.2.353</ArticleId>
            <ArticleId IdType="pubmed">10411511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lønning P, Pfister C, Martoni A, Zamagni C. Pharmacokinetics of Third-Generation Aromatase Inhibitors. Semin Oncol (2003) 30:23–32. 10.1016/S0093-7754(03)00305-1
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0093-7754(03)00305-1</ArticleId>
            <ArticleId IdType="pubmed">14513434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yding Andersen C. Inhibin-B Secretion and FSH Isoform Distribution may Play an Integral Part of Follicular Selection in the Natural Menstrual Cycle. Mol Hum Reprod (2017) 23:16–24. 10.1093/molehr/gaw070
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/molehr/gaw070</ArticleId>
            <ArticleId IdType="pubmed">27756855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Knight PG, Glister C. Local Roles of TGF-Beta Superfamily Members in the Control of Ovarian Follicle Development. Anim Reprod Sci (2003) 78:165–83. 10.1016/S0378-4320(03)00089-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0378-4320(03)00089-7</ArticleId>
            <ArticleId IdType="pubmed">12818643</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kranc W, Budna J, Kahan R, Chachuła A, Bryja A, Ciesiółka S, et al. . Molecular Basis of Growth, Proliferation, and Differentiation of Mammalian Follicular Granulosa Cells. J Biol Regulators Homeostatic Agents (2017) 31:1–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28337864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Randall JM, Templeton A. Cervical Mucus Score and In Vitro Sperm Mucus Interaction in Spontaneous and Clomiphene Citrate Cycles. Fertil Steril (1991) 56:465–8. 10.1016/S0015-0282(16)54541-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0015-0282(16)54541-5</ArticleId>
            <ArticleId IdType="pubmed">1894023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Franks S, Adams J, Mason H, Polson D. Ovulatory Disorders in Women With Polycystic Ovary Syndrome. Clin Obstet Gynaecol (1985) 12:605–32. 10.1016/S0306-3356(21)00138-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0306-3356(21)00138-2</ArticleId>
            <ArticleId IdType="pubmed">3933879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Casper RF, Mitwally MF. A Historical Perspective of Aromatase Inhibitors for Ovulation Induction. Fertil Steril (2012) 98:1352–5. 10.1016/j.fertnstert.2012.10.008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2012.10.008</ArticleId>
            <ArticleId IdType="pubmed">23200665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bao SH, Sheng SL, Peng YF, Lin QD. Effects of Letrozole and Clomiphene Citrate on the Expression of HOXA10 and Integrin Alpha V Beta 3 in Uterine Epithelium of Rats. Fertil Steril (2009) 91:244–8. 10.1016/j.fertnstert.2007.11.024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2007.11.024</ArticleId>
            <ArticleId IdType="pubmed">18249394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Crosignani PG, Bianchedi D, Riccaboni A, Vegetti W. Management of Anovulatory Infertility. Hum Reprod (1999) 14(Suppl 1):108–19. 10.1093/humrep/14.suppl_1.108
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/14.suppl_1.108</ArticleId>
            <ArticleId IdType="pubmed">10573028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang R, Kim BV, van Wely M, Johnson NP, Costello MF, Zhang H, et al. . Treatment Strategies for Women With WHO Group II Anovulation: Systematic Review and Network Meta-Analysis. Bmj (2017) 356:j138. 10.1136/bmj.j138
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.j138</ArticleId>
            <ArticleId IdType="pmc">PMC5421445</ArticleId>
            <ArticleId IdType="pubmed">28143834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hu S, Yu Q, Wang Y, Wang M, Xia W, Zhu C. Letrozole Versus Clomiphene Citrate in Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials. Arch Gynecol Obstetrics (2018) 297:1081–8. 10.1007/s00404-018-4688-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00404-018-4688-6</ArticleId>
            <ArticleId IdType="pubmed">29392438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Roque M, Tostes AC, Valle M, Sampaio M, Geber S. Letrozole Versus Clomiphene Citrate in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol (2015) 31:917–21. 10.3109/09513590.2015.1096337
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09513590.2015.1096337</ArticleId>
            <ArticleId IdType="pubmed">26479460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Franik S, Eltrop SM, Kremer JA, Kiesel L, Farquhar C. Aromatase Inhibitors (Letrozole) for Subfertile Women With Polycystic Ovary Syndrome. Cochrane Database Systematic Rev (2018) 5:CD010287. 10.1002/14651858.CD010287.pub3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD010287.pub3</ArticleId>
            <ArticleId IdType="pmc">PMC6494577</ArticleId>
            <ArticleId IdType="pubmed">29797697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gadalla MA, Norman RJ, Tay CT, Hiam DS, Melder A, Pundir J, et al. . Medical and Surgical Treatment of Reproductive Outcomes in Polycystic Ovary Syndrome: An Overview of Systematic Reviews. Int J Fertil Steril (2020) 13:257–70.  10.22074/ijfs.2020.5608
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.22074/ijfs.2020.5608</ArticleId>
            <ArticleId IdType="pmc">PMC6875858</ArticleId>
            <ArticleId IdType="pubmed">31710185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Azim A, Oktay K. Letrozole for Ovulation Induction and Fertility Preservation by Embryo Cryopreservation in Young Women With Endometrial Carcinoma. Fertil Steril (2007) 88:657–64. 10.1016/j.fertnstert.2006.12.068
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2006.12.068</ArticleId>
            <ArticleId IdType="pubmed">17428480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yu Q, Hu S, Wang Y, Cheng G, Xia W, Zhu C. Letrozole Versus Laparoscopic Ovarian Drilling in Clomiphene Citrate-Resistant Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Reprod Biol Endocrinol (2019) 17:17. 10.1186/s12958-019-0461-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12958-019-0461-3</ArticleId>
            <ArticleId IdType="pmc">PMC6366034</ArticleId>
            <ArticleId IdType="pubmed">30728032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Casper RF, Mitwally MF. Use of the Aromatase Inhibitor Letrozole for Ovulation Induction in Women With Polycystic Ovarian Syndrome. Clin Obstetrics Gynecol (2011) 54:685–95. 10.1097/GRF.0b013e3182353d0f
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/GRF.0b013e3182353d0f</ArticleId>
            <ArticleId IdType="pubmed">22031258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Abu Hashim H, El Rakhawy M, Abd Elaal I. Randomized Comparison of Superovulation With Letrozole vs. Clomiphene Citrate in an IUI Program for Women With Recently Surgically Treated Minimal to Mild Endometriosis. Acta Obstet Gynecol Scand (2012) 91:338–45. 10.1111/j.1600-0412.2011.01346.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-0412.2011.01346.x</ArticleId>
            <ArticleId IdType="pubmed">22181973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zadehmodares S, Niyakan M, Sharafy SA, Yazdi MH, Jahed F. Comparison of Treatment Outcomes of Infertile Women by Clomiphene Citrate and Letrozole With Gonadotropins Underwent Intrauterine Insemination. Acta Med Iran (2012) 50:18–20.  10.22074/ijfs.2020.5608
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.22074/ijfs.2020.5608</ArticleId>
            <ArticleId IdType="pubmed">22267373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bayar U, Tanriverdi HA, Barut A, Ayoğlu F, Ozcan O, Kaya E. Letrozole vs. Clomiphene Citrate in Patients With Ovulatory Infertility. Fertil Steril (2006) 85:1045–8. 10.1016/j.fertnstert.2005.09.045
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2005.09.045</ArticleId>
            <ArticleId IdType="pubmed">16580393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mejia RB, Summers KM, Kresowik JD, Van Voorhis BJ. A Randomized Controlled Trial of Combination Letrozole and Clomiphene Citrate or Letrozole Alone for Ovulation Induction in Women With Polycystic Ovary Syndrome. Fertil Steril (2019) 111:571–578.e571.  10.1016/j.fertnstert.2018.11.030
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2018.11.030</ArticleId>
            <ArticleId IdType="pubmed">30683591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Diamond MP, Mitwally M, Casper R, Ager J, Legro RS, Brzyski R, et al. . Estimating Rates of Multiple Gestation Pregnancies: Sample Size Calculation From the Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation (AMIGOS) Trial. Contemp Clin Trials (2011) 32:902–8. 10.1016/j.cct.2011.07.009
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cct.2011.07.009</ArticleId>
            <ArticleId IdType="pmc">PMC3708642</ArticleId>
            <ArticleId IdType="pubmed">21787883</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fouda UM, Sayed AM. Extended Letrozole Regimen Versus Clomiphene Citrate for Superovulation in Patients With Unexplained Infertility Undergoing Intrauterine Insemination: A Randomized Controlled Trial. Reprod Biol Endocrinol (2011) 9:84. 10.1186/1477-7827-9-84
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1477-7827-9-84</ArticleId>
            <ArticleId IdType="pmc">PMC3135532</ArticleId>
            <ArticleId IdType="pubmed">21693030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Eskew AM, Bedrick BS, Hardi A, Stoll CRT, Colditz GA, Tuuli MG, et al. . Letrozole Compared With Clomiphene Citrate for Unexplained Infertility: A Systematic Review and Meta-Analysis. Obstetrics Gynecol (2019) 133:437–44. 10.1097/AOG.0000000000003105
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0000000000003105</ArticleId>
            <ArticleId IdType="pubmed">30741800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Quaas AM, Gavrizi SZ, Peck JD, Diamond MP, Legro RS, Robinson RD, et al. . Endometrial Thickness After Ovarian Stimulation With Gonadotropin, Clomiphene, or Letrozole for Unexplained Infertility, and Association With Treatment Outcomes. Fertil Steril (2021) 115:213–20. 10.1016/j.fertnstert.2020.07.030
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2020.07.030</ArticleId>
            <ArticleId IdType="pmc">PMC7796980</ArticleId>
            <ArticleId IdType="pubmed">32972733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tei C, Maruyama T, Kuji N, Miyazaki T, Mikami M, Yoshimura Y. Reduced Expression of Alphavbeta3 Integrin in the Endometrium of Unexplained Infertility Patients With Recurrent IVF-ET Failures: Improvement by Danazol Treatment. J Assist Reprod Genet (2003) 20:13–20. 10.1023/A:1021254620888
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/A:1021254620888</ArticleId>
            <ArticleId IdType="pmc">PMC3455802</ArticleId>
            <ArticleId IdType="pubmed">12645863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ganesh A, Chauhan N, Das S, Chakravarty B, Chaudhury K. Endometrial Receptivity Markers in Infertile Women Stimulated With Letrozole Compared With Clomiphene Citrate and Natural Cycles. Syst Biol Reprod Med (2014) 60:105–11. 10.3109/19396368.2013.862316
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/19396368.2013.862316</ArticleId>
            <ArticleId IdType="pubmed">24304327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Garcia-Velasco JA, Moreno L, Pacheco A, Guillen A, Duque L, Requena A, et al. . The Aromatase Inhibitor Letrozole Increases the Concentration of Intraovarian Androgens and Improves In Vitro Fertilization Outcome in Low Responder Patients: A Pilot Study. Fertil Steril (2005) 84:82–7. 10.1016/j.fertnstert.2005.01.117
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2005.01.117</ArticleId>
            <ArticleId IdType="pubmed">16009161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lazer T, Dar S, Shlush E, Al Kudmani BS, Quach K, Sojecki A, et al. . Comparison of IVF Outcomes Between Minimal Stimulation and High-Dose Stimulation for Patients With Poor Ovarian Reserve. Int J Reprod Med (2014) 2014:581451. 10.1155/2014/581451
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/581451</ArticleId>
            <ArticleId IdType="pmc">PMC4334044</ArticleId>
            <ArticleId IdType="pubmed">25763403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Haas J, Casper RF. In Vitro Fertilization Treatments With the Use of Clomiphene Citrate or Letrozole. Fertil Steril (2017) 108:568–71. 10.1016/j.fertnstert.2017.08.017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2017.08.017</ArticleId>
            <ArticleId IdType="pubmed">28965550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shapira M, Orvieto R, Lebovitz O, Nahum R, Aizer A, Segev-Zahav A, et al. . Does Daily Co Administration of Gonadotropins and Letrozole During the Ovarian Stimulation Improve IVF Outcome for Poor and Sub Optimal Responders? J Ovarian Res (2020) 13:66. 10.1186/s13048-020-00666-z
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13048-020-00666-z</ArticleId>
            <ArticleId IdType="pmc">PMC7282086</ArticleId>
            <ArticleId IdType="pubmed">32513279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
D’Amato G, Caringella AM, Stanziano A, Cantatore C, Palini S, Caroppo E. Mild Ovarian Stimulation With Letrozole Plus Fixed Dose Human Menopausal Gonadotropin Prior to IVF/ICSI for Infertile non-Obese Women With Polycystic Ovarian Syndrome Being Pre-Treated With Metformin: A Pilot Study. Reprod Biol Endocrinol (2018) 16:89. 10.1186/s12958-018-0405-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12958-018-0405-3</ArticleId>
            <ArticleId IdType="pmc">PMC6137735</ArticleId>
            <ArticleId IdType="pubmed">30217209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ecemis T, Tasci Y, Caglar GS. Controlled Ovarian Hyperstimulation With Sequential Letrozole Co-Treatment in Normo/High Responders. Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol (2016) 32:206–9. 10.3109/09513590.2015.1110133
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09513590.2015.1110133</ArticleId>
            <ArticleId IdType="pubmed">26487376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Miller PB, Parnell BA, Bushnell G, Tallman N, Forstein DA, Higdon HL, 3rd, et al. . Endometrial Receptivity Defects During IVF Cycles With and Without Letrozole. Hum Reprod (2012) 27:881–8. 10.1093/humrep/der452
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/der452</ArticleId>
            <ArticleId IdType="pmc">PMC3279128</ArticleId>
            <ArticleId IdType="pubmed">22246449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rose BI. The Potential of Letrozole Use for Priming In Vitro Maturation Cycles. Facts Views Vision ObGyn (2014) 6:150–5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4216981</ArticleId>
            <ArticleId IdType="pubmed">25374658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kamath MS, Maheshwari A, Bhattacharya S, Lor KY, Gibreel A. Oral Medications Including Clomiphene Citrate or Aromatase Inhibitors With Gonadotropins for Controlled Ovarian Stimulation in Women Undergoing In Vitro Fertilisation. Cochrane Database Systematic Rev (2017) 11:Cd008528. 10.1002/14651858.CD008528.pub3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD008528.pub3</ArticleId>
            <ArticleId IdType="pmc">PMC6486039</ArticleId>
            <ArticleId IdType="pubmed">29096046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chuderland D, Ben-Ami I, Kaplan-Kraicer R, Grossman H, Ron-El R, Shalgi R. The Role of Pigment Epithelium-Derived Factor in the Pathophysiology and Treatment of Ovarian Hyperstimulation Syndrome in Mice. J Clin Endocrinol Metab (2013) 98:E258–66. 10.1210/jc.2012-3037
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2012-3037</ArticleId>
            <ArticleId IdType="pubmed">23295464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sahin N, Apaydin N, Toz E, Sivrikoz ON, Genc M, Turan GA, et al. . Comparison of the Effects of Letrozole and Cabergoline on Vascular Permeability, Ovarian Diameter, Ovarian Tissue VEGF Levels, and Blood PEDF Levels, in a Rat Model of Ovarian Hyperstimulation Syndrome. Arch Gynecol Obstetrics (2016) 293:1101–6. 10.1007/s00404-015-3987-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00404-015-3987-4</ArticleId>
            <ArticleId IdType="pubmed">26690356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tshzmachyan R, Hambartsoumian E. The Role of Letrozole (LE) in Controlled Ovarian Stimulation (COS) in Patients at High Risk to Develop Ovarian Hyper Stimulation Syndrome (OHSS). A Prospective Randomized Controlled Pilot Study. J Gynecol Obstet Hum Reprod (2019) 49:101643. 10.1016/j.jogoh.2019.101643
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jogoh.2019.101643</ArticleId>
            <ArticleId IdType="pubmed">31563697</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang Y-Q, Luo J, Xu W-M, Xie Q-Z, Yan W-J, Wu G-X, et al. . Can Steroidal Ovarian Suppression During the Luteal Phase After Oocyte Retrieval Reduce the Risk of Severe OHSS? J Ovarian Res (2015) 8:63. 10.1186/s13048-015-0190-y
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13048-015-0190-y</ArticleId>
            <ArticleId IdType="pmc">PMC4579791</ArticleId>
            <ArticleId IdType="pubmed">26400057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang J, Liu H, Wang Y, Mao X, Chen Q, Fan Y, et al. . Letrozole Use During Frozen Embryo Transfer Cycles in Women With Polycystic Ovary Syndrome. Fertil Steril (2019) 112:371–7. 10.1016/j.fertnstert.2019.04.014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2019.04.014</ArticleId>
            <ArticleId IdType="pubmed">31126712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tatsumi T, Jwa SC, Kuwahara A, Irahara M, Kubota T, Saito H. Pregnancy and Neonatal Outcomes Following Letrozole Use in Frozen-Thawed Single Embryo Transfer Cycles. Hum Reprod (2017) 32:1244–8. 10.1093/humrep/dex066
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/dex066</ArticleId>
            <ArticleId IdType="pubmed">28398491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mackens S, Santos-Ribeiro S, van de Vijver A, Racca A, Van Landuyt L, Tournaye H, et al. . Frozen Embryo Transfer: A Review on the Optimal Endometrial Preparation and Timing. Hum Reprod (2017) 32:2234–42. 10.1093/humrep/dex285
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/dex285</ArticleId>
            <ArticleId IdType="pubmed">29025055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yarali H, Polat M, Mumusoglu S, Yarali I, Bozdag G. Preparation of Endometrium for Frozen Embryo Replacement Cycles: A Systematic Review and Meta-Analysis. J Assisted Reprod Genet (2016) 33:1287–304. 10.1007/s10815-016-0787-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10815-016-0787-0</ArticleId>
            <ArticleId IdType="pmc">PMC5065562</ArticleId>
            <ArticleId IdType="pubmed">27549760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Glujovsky D, Pesce R, Sueldo C, Quinteiro Retamar AM, Hart RJ, Ciapponi A. Endometrial Preparation for Women Undergoing Embryo Transfer With Frozen Embryos or Embryos Derived From Donor Oocytes. Cochrane Database Systematic Rev (2020) 10:Cd006359. 10.1002/14651858.CD006359.pub3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/14651858.CD006359.pub3</ArticleId>
            <ArticleId IdType="pmc">PMC8094620</ArticleId>
            <ArticleId IdType="pubmed">33112418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Abu Hashim H. Potential Role of Aromatase Inhibitors in the Treatment of Endometriosis. Int J Women’s Health (2014) 6:671–80. 10.2147/IJWH.S34684
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/IJWH.S34684</ArticleId>
            <ArticleId IdType="pmc">PMC4113402</ArticleId>
            <ArticleId IdType="pubmed">25092998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alborzi S, Hamedi B, Omidvar A, Dehbashi S, Alborzi S, Alborzi M. A Comparison of the Effect of Short-Term Aromatase Inhibitor (Letrozole) and GnRH Agonist (Triptorelin) Versus Case Control on Pregnancy Rate and Symptom and Sign Recurrence After Laparoscopic Treatment of Endometriosis. Arch Gynecol Obstetrics (2011) 284:105–10. 10.1007/s00404-010-1599-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00404-010-1599-6</ArticleId>
            <ArticleId IdType="pubmed">20661580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen C, Sun S, Yuan JP, Wang YH, Cao TZ, Zheng HM, et al. . Characteristics of Breast Cancer in Central China, Literature Review and Comparison With USA. Breast (2016) 30:208–13. 10.1016/j.breast.2016.01.004
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.breast.2016.01.004</ArticleId>
            <ArticleId IdType="pubmed">27017410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lambertini M, Peccatori FA, Demeestere I, Amant F, Wyns C, Stukenborg JB, et al. . Fertility Preservation and Post-Treatment Pregnancies in Post-Pubertal Cancer Patients: ESMO Clinical Practice Guidelines(†). Ann Oncology: Off J Eur Soc Med Oncol (2020) 31:1664–78. 10.1016/j.annonc.2020.09.006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.annonc.2020.09.006</ArticleId>
            <ArticleId IdType="pubmed">32976936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pereira N, Hancock K, Cordeiro CN, Lekovich JP, Schattman GL, Rosenwaks Z. Comparison of Ovarian Stimulation Response in Patients With Breast Cancer Undergoing Ovarian Stimulation With Letrozole and Gonadotropins to Patients Undergoing Ovarian Stimulation With Gonadotropins Alone for Elective Cryopreservation of Oocytesdagger. Gynecol Endocrinol: Off J Int Soc Gynecol Endocrinol (2016) 32:823–6. 10.1080/09513590.2016.1177013
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09513590.2016.1177013</ArticleId>
            <ArticleId IdType="pubmed">27114051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bonardi B, Massarotti C, Bruzzone M, Goldrat O, Mangili G, Anserini P, et al. . Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis. Front Oncol (2020) 10:574669. 10.3389/fonc.2020.574669
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fonc.2020.574669</ArticleId>
            <ArticleId IdType="pmc">PMC7575927</ArticleId>
            <ArticleId IdType="pubmed">33117711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Goldrat O, Gervy C, Englert Y, Delbaere A, Demeestere I. Progesterone Levels in Letrozole Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer Patients. Hum Reprod (2015) 30:2184–9. 10.1093/humrep/dev155
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/dev155</ArticleId>
            <ArticleId IdType="pubmed">26109617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Quinn MM, Cakmak H, Letourneau JM, Cedars MI, Rosen MP. Response to Ovarian Stimulation is Not Impacted by a Breast Cancer Diagnosis. Hum Reprod (2017) 32:568–74. 10.1093/humrep/dew355
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/dew355</ArticleId>
            <ArticleId IdType="pubmed">28122888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Oktay K, Turan V, Bedoschi G, Pacheco Fernanda S, Moy F. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer. J Clin Oncol (2015) 33:2424–9. 10.1200/JCO.2014.59.3723
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2014.59.3723</ArticleId>
            <ArticleId IdType="pmc">PMC4507464</ArticleId>
            <ArticleId IdType="pubmed">26101247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kawahara T, Okamoto N, Takae S, Kashiwagi M, Nakajima M, Uekawa A, et al. . Aromatase Inhibitor Use During Ovarian Stimulation Suppresses Growth of Uterine Endometrial Cancer in Xenograft Mouse Model. Hum Reprod (2018) 33:303–10. 10.1093/humrep/dex368
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/dex368</ArticleId>
            <ArticleId IdType="pubmed">29300901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhang Z, Huang H, Feng F, Wang J, Cheng N. A Pilot Study of Gonadotropin-Releasing Hormone Agonist Combined With Aromatase Inhibitor as Fertility-Sparing Treatment in Obese Patients With Endometrial Cancer. J Gynecologic Oncol (2019) 30:e61. 10.3802/jgo.2019.30.e61
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3802/jgo.2019.30.e61</ArticleId>
            <ArticleId IdType="pmc">PMC6543109</ArticleId>
            <ArticleId IdType="pubmed">31074242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mangili G, Somigliana E, Giorgione V, Martinelli F, Filippi F, Petrella MC, et al. . Fertility Preservation in Women With Borderline Ovarian Tumours. Cancer Treat Rev (2016) 49:13–24. 10.1016/j.ctrv.2016.06.010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ctrv.2016.06.010</ArticleId>
            <ArticleId IdType="pubmed">27428850</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, et al. . Congenital Malformations Among 911 Newborns Conceived After Infertility Treatment With Letrozole or Clomiphene Citrate. Fertil Steril (2006) 85:1761–5. 10.1016/j.fertnstert.2006.03.014
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.fertnstert.2006.03.014</ArticleId>
            <ArticleId IdType="pubmed">16650422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tatsumi T, Jwa SC, Kuwahara A, Irahara M, Kubota T, Saito H. No Increased Risk of Major Congenital Anomalies or Adverse Pregnancy or Neonatal Outcomes Following Letrozole Use in Assisted Reproductive Technology. Hum Reprod (2017) 32:125–32. 10.1093/humrep/dew280
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/humrep/dew280</ArticleId>
            <ArticleId IdType="pubmed">27821708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pritts EA. Letrozole for Ovulation Induction and Controlled Ovarian Hyperstimulation. Curr Opin Obstet Gynecol (2010) 22:289–94. 10.1097/GCO.0b013e32833beebf
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/GCO.0b013e32833beebf</ArticleId>
            <ArticleId IdType="pubmed">20592587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hoffman JI. Incidence of Congenital Heart Disease: I. Postnatal Incidence. Pediatr Cardiol (1995) 16:103–13. 10.1007/BF00801907
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00801907</ArticleId>
            <ArticleId IdType="pubmed">7617503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Roselli CE, Klosterman S, Resko JA. Anatomic Relationships Between Aromatase and Androgen Receptor mRNA Expression in the Hypothalamus and Amygdala of Adult Male Cynomolgus Monkeys. J Comp Neurol (2001) 439:208–23. 10.1002/cne.1343
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.1343</ArticleId>
            <ArticleId IdType="pubmed">11596049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hurria A, Patel SK, Mortimer J, Luu T, Somlo G, Katheria V, et al. . The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients With Breast Cancer. Clin Breast Cancer (2014) 14:132–40. 10.1016/j.clbc.2013.10.010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clbc.2013.10.010</ArticleId>
            <ArticleId IdType="pmc">PMC4103787</ArticleId>
            <ArticleId IdType="pubmed">24291380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bender CM, Merriman JD, Gentry AL, Ahrendt GM, Berga SL, Brufsky AM, et al. . Patterns of Change in Cognitive Function With Anastrozole Therapy. Cancer (2015) 121:2627–36. 10.1002/cncr.29393
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cncr.29393</ArticleId>
            <ArticleId IdType="pmc">PMC4512875</ArticleId>
            <ArticleId IdType="pubmed">25906766</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Karatas F, Akin S, Babacan T, Sever AR, Altundag K. Can Aromatase Inhibitors Cause Forgetfulness in Women With Breast Cancer? J BUON: Off J Balkan Union Oncol (2015) 20:935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26214652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rune GM, Lohse C, Prange-Kiel J, Fester L, Frotscher M. Synaptic Plasticity in the Hippocampus: Effects of Estrogen From the Gonads or Hippocampus?  Neurochemical Res (2006) 31:145–55. 10.1007/s11064-005-9004-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11064-005-9004-8</ArticleId>
            <ArticleId IdType="pubmed">16673174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vierk R, Bayer J, Freitag S, Muhia M, Kutsche K, Wolbers T, et al. . Structure-Function-Behavior Relationship in Estrogen-Induced Synaptic Plasticity. Hormones Behav (2015) 74:139–48. 10.1016/j.yhbeh.2015.05.008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yhbeh.2015.05.008</ArticleId>
            <ArticleId IdType="pubmed">26012713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bayer J, Rune G, Schultz H, Tobia MJ, Mebes I, Katzler O, et al. . The Effect of Estrogen Synthesis Inhibition on Hippocampal Memory. Psychoneuroendocrinology (2015) 56:213–25. 10.1016/j.psyneuen.2015.03.011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psyneuen.2015.03.011</ArticleId>
            <ArticleId IdType="pubmed">25863445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S. Does Hormone Therapy for the Treatment of Breast Cancer Have a Detrimental Effect on Memory and Cognition? A Pilot Study. Psycho-oncology (2004) 13:61–6. 10.1002/pon.709
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pon.709</ArticleId>
            <ArticleId IdType="pubmed">14745746</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rocha-Cadman X, Massie MJ, Du Hamel K. Aromatase Inhibitors and Mood Disturbances. Palliative Supportive Care (2012) 10:225–7. 10.1017/S1478951512000636
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1478951512000636</ArticleId>
            <ArticleId IdType="pmc">PMC6048955</ArticleId>
            <ArticleId IdType="pubmed">22677000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Palomba S. Aromatase Inhibitors for Ovulation Induction. J Clin Endocrinol Metab (2015) 100:1742–7. 10.1210/jc.2014-4235
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2014-4235</ArticleId>
            <ArticleId IdType="pubmed">25710566</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
